DSE:GENEXIL

Genex Infosys PLC announcements

128 Dhaka Stock Exchange announcements for Genex Infosys PLC (GENEXIL) since 2021: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2025 (21).

  1. Resumption after Record Date

    Trading of the shares of the company will resume on 22.12.2025.

  2. Suspension for Record Date

    Trading of the shares of the company will remain suspended on record date i.e., 21.12.2025.

  3. Q1 Financials

    (Q1 Un-audited): Consolidated EPS was Tk. 0.81 for July-September 2025 as against Tk. 0.69 for July-September 2024; Consolidated NOCFPS was Tk. 1.67 for July-September 2025 as against Tk. 0.91 for July-September 2024. Consolidated NAV per share was Tk. 23.14 as on September 30, 2025 and Tk. 22.11 as on June 30, 2025.

  4. Spot News

    Trading of the shares of the company will be allowed only in the Spot Market and Block transaction will also be settled as per spot settlement cycle with cum benefit from 17.12.2025 to 18.12.2025 and trading of the shares will remain suspended on record date i.e., 21.12.2025.

  5. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on December 15, 2025 at 4:30 PM to consider, among others, Un-audited financial statements of the Company for the First Quarter (Q1) period ended September 30, 2025.

  6. Dividend Declaration

    The Board of Directors has recommended 1% Cash Dividend excluding Sponsors and Directors for the year ended June 30, 2025. The Sponsors and Directors hold 36,195,732 shares out of the total 120,450,021 shares of the company and Cash Dividend payable to the General Shareholders is Tk. 8,425,429.00. Date of AGM: 30.12.2025, Time: 11:00 AM, Venue/Mode: Hybrid System and at RAOWA Convention Hall. Record Date: 21.12.2025. (cont.) (Cont. News of GENEXIL): The Company has also reported Consolidated EPS of Tk. 2.17, Consolidated NAV per share of Tk. 22.11 and Consolidated NOCFPS of Tk. 6.87 for the year ended June 30, 2025 as against Tk. 2.62, Tk. 20.38 and Tk. 1.85 respectively for the year ended June 30, 2024. (end)

  7. Price Limit Open

    There will be no price limit on the trading of the shares of the Company today (07.12.2025) following its corporate declaration.

  8. Board Meeting schedule under LR 19(1)

    As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on December 04, 2025 at 5:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2025.

  9. Appointment of Chairman (Acting)

    The company has informed that the Board of Directors has decided to appoint Mr. Hassan Shahid Sarwar FCA as the Chairman (Acting) of the Board with effect from October 09, 2025.

  10. CSE's Query Reply

    In response to a CSE query dated September 30, 2025, regarding the unusual upward trend of its share price and volume, the company has informed that there has been no undisclosed price-sensitive information, decision, or event within the company that could have caused such movement in the share price or trading volume.

  11. Dividend Disbursement

    The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2024 to the respective shareholders.

  12. Category Change

    The Company will be placed in 'B' category from existing 'Z' category with effect from September 29, 2025 as the Company has reported disbursement of 3% Cash Dividend for the year ended June 30, 2024.

  13. Prohibition on providing loan facilities to purchase securities

    The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase the securities of Genex Infosys PLC in between 1st to 7th trading days following the change of categorization, with effect from September 29, 2025 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.

  14. Appointment of Company Secretary

    The Board of Directors of the company has appointed Mr. Riaz Uddin Bhuiya as the company secretary of the company with effect from October 01, 2025.

  15. Q3 Financials

    (Q3 Un-audited): Consolidated EPS was Tk. 0.85 for January-March 2025 as against Tk. 0.94 for January-March 2024; Consolidated EPS was Tk. 2.10 for July 2024-March 2025 as against Tk. 2.54 for July 2023-March 2024. Consolidated NOCFPS was Tk. 4.09 for July 2024-March 2025 as against Tk. 2.69 for July 2023-March 2024. Consolidated NAV per share was Tk. 22.18 as on March 31, 2025 and Tk. 20.38 as on June 30, 2024.

  16. Reschedule of Board Meeting under LR 16(1)

    The Company has further informed that the meeting of the Board of Directors of the Company as per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, will be held on April 30, 2025 at 5:00 PM instead of April 29, 2025 to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.

  17. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2025 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended March 31, 2025.

  18. Category Change

    The Company has been placed in 'Z' category from existing 'B' category with effect from today i.e., 11.02.2025 as per provision 1(e) of BSEC Directive No. BSEC/CMRRCD/2009-193/77, dated May 20, 2024 regarding non-disbursement of the approved dividend within the stipulated time frame.

  19. Prohibition on providing loan facilities to purchase securities

    The Stock Brokers and Merchant Bankers are requested to abstain from providing loan facilities to purchase securities of Genex Infosys PLC with effect from today i.e., 11.02.2025 as per BSEC Directive No. BSEC/CMRRCD/2009-193/32 dated December 26, 2021.

  20. Q2 Financials

    (Q2 Un-audited): Consolidated EPS was Tk. 0.57 for October-December 2024 as against Tk. 0.78 for October-December 2023; Consolidated EPS was Tk. 1.25 for July-December 2024 as against Tk. 1.60 for July-December 2023. Consolidated NOCFPS was Tk. 2.73 for July-December 2024 as against Tk. 2.38 for July-December 2023. Consolidated NAV per share was Tk. 21.40 as on December 31, 2024 and Tk. 20.38 as on June 30, 2024.

  21. Board Meeting schedule under LR 16(1)

    As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 29, 2025 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended December 31, 2024.

Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.